Prediction of response to immune checkpoint inhibitor therapy using early-time-point 18F-FDG PET/CT imaging in patients with advanced melanoma
The Journal of Nuclear Medicine Sep 08, 2017
Cho SY, et al. - The 18F-FDG PET/CT scanning was examined in this research, as an early predictor of response to immune checkpoint inhibitors (ICIs) in patients with advanced melanoma. The functional and anatomic imaging parameters' combination from 18F-FDG PET/CT scans performed early in ICI was speculative of the eventual response in patients with advanced melanoma. However, advanced research was warranted.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
